AAAAAA
Results:
1-12
|
Results: 12
Authors:
Birner, P
Oberhuber, G
Stani, J
Reithofer, C
Samonigg, H
Hausmaninger, H
Kubista, E
Kwasny, W
Kandioler-Eckersberger, D
Gnant, M
Jakesz, R
Citation: P. Birner et al., Evaluation of the United States food and drug administration-approved scoring and test system of HER-2 protein expression in breast cancer, CLIN CANC R, 7(6), 2001, pp. 1669-1675
Authors:
Latinovic, L
Heinze, G
Birner, P
Samonigg, H
Hausmaninger, H
Kubista, E
Kwasny, W
Gnant, M
Jakesz, R
Oberhuber, G
Citation: L. Latinovic et al., Prognostic relevance of three histological grading methods in breast cancer, INT J ONCOL, 19(6), 2001, pp. 1271-1277
Authors:
Dobrzanski, LA
Kwasny, W
Shishkov, R
Madejski, J
Citation: La. Dobrzanski et al., Effect of the deposition parameters on the properties of the two-layer surface coatings obtained using magnetron sputtering, J MATER PR, 113(1-3), 2001, pp. 493-501
Authors:
Kornek, GV
Ulrich-Pur, H
Penz, M
Haider, K
Kwasny, W
Depisch, D
Kovats, E
Lang, F
Schneeweiss, B
Scheithauer, W
Citation: Gv. Kornek et al., Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor, J CL ONCOL, 19(3), 2001, pp. 621-627
Authors:
Scheithauer, W
Kornek, GV
Ulrich-Pur, H
Penz, M
Raderer, M
Salek, T
Haider, K
Kwasny, W
Depisch, D
Citation: W. Scheithauer et al., Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial, CANCER, 91(7), 2001, pp. 1264-1271
Authors:
Kwasny, W
Kornek, G
Haider, K
Valencak, J
Ulrich-Pur, H
Penz, M
Lang, F
Depisch, D
Scheithauer, W
Citation: W. Kwasny et al., Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor, BREAST CANC, 63(3), 2000, pp. 235-241
Authors:
Ulrich-Pur, H
Kornek, GV
Raderer, M
Haider, K
Kwasny, W
Depisch, D
Greul, R
Schneeweiss, B
Krauss, G
Funovics, J
Scheithauer, W
Citation: H. Ulrich-pur et al., A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma, CANCER, 88(11), 2000, pp. 2505-2511
Authors:
Kornek, GV
Schratter-Sehn, A
Marczell, A
Depisch, D
Karner, J
Krauss, G
Haider, K
Kwasny, W
Locker, G
Scheithauer, W
Citation: Gv. Kornek et al., Treatment of unresectable, locally advanced pancreatic adenocarcinoma withcombined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin, BR J CANC, 82(1), 2000, pp. 98-103
Authors:
Scheithauer, W
Kornek, GV
Raderer, M
Valencak, J
Weinlander, G
Hejna, M
Haider, K
Kwasny, W
Depisch, D
Citation: W. Scheithauer et al., Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer, J CL ONCOL, 17(3), 1999, pp. 902-906
Authors:
Valencak, J
Kornek, GV
Raderer, M
Ulrich-Pur, H
Krauss, G
Greul, R
Pidlich, J
Pfeffel, F
Haider, K
Kwasny, W
Schneeweiss, B
Scheithauer, W
Citation: J. Valencak et al., Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens, ONKOLOGIE, 22(6), 1999, pp. 498-501
Authors:
Ulrich-Pur, H
Raderer, M
Kornek, GV
Haider, K
Kwasny, W
Krauss, G
Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced gastric cancer with oral idarubicin, leucovorin, andtegafur, ONKOLOGIE, 22(4), 1999, pp. 292-294
Authors:
Haider, K
Kornek, GV
Kwasny, W
Weinlander, G
Valencak, J
Lang, F
Puribauer, F
Kovats, E
Depisch, D
Scheithauer, W
Citation: K. Haider et al., Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor, BREAST CANC, 55(3), 1999, pp. 203-211
Risultati:
1-12
|